{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T14:33:46Z","timestamp":1783521226320,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FDN-143347"],"award-info":[{"award-number":["FDN-143347"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-137066"],"award-info":[{"award-number":["MOP-137066"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000015","name":"Canadian Cancer Society Research Institute","doi-asserted-by":"publisher","award":["703 032"],"award-info":[{"award-number":["703 032"]}],"id":[{"id":"10.13039\/501100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Quebec Health Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015631","name":"Merck Canada Inc","doi-asserted-by":"publisher","award":["101950"],"award-info":[{"award-number":["101950"]}],"id":[{"id":"10.13039\/501100015631","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.vaccine.2024.126644","type":"journal-article","created":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T00:41:15Z","timestamp":1734741675000},"page":"126644","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["HPV vaccination and anal HPV infection in gay, bisexual, and other men who have sex with men"],"prefix":"10.1016","volume":"45","author":[{"given":"Pareesa","family":"Kassam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"El-Zein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph E.","family":"Tota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Paul","family":"Tellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Coutl\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"de Pokomandy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo L.","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.vaccine.2024.126644_bb0005","doi-asserted-by":"crossref","first-page":"e531","DOI":"10.1016\/S2352-3018(21)00108-9","article-title":"Epidemiology of anal human papillomavirus infection and high-grade squamous intraepithelial lesions in 29 900 men according to HIV status, sexuality, and age: a collaborative pooled analysis of 64 studies","volume":"8","author":"Wei","year":"2021","journal-title":"Lancet HIV"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126644_bb0010","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ijc.33185","article-title":"A meta-analysis of anal cancer incidence by risk group: toward a unified anal cancer risk scale","volume":"148","author":"Clifford","year":"2021","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.vaccine.2024.126644_bb0015","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ijc.30716","article-title":"Worldwide burden of cancer attributable to HPV by site, country and HPV type","volume":"141","author":"de Martel","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vaccine.2024.126644_bb0020","article-title":"Human papillomavirus (HPV) vaccination program","volume":"1","year":"2020","journal-title":"Gouvernment du Qu\u00e9bec Updated September"},{"key":"10.1016\/j.vaccine.2024.126644_bb0030","article-title":"Recent developments in human papillomavirus (HPV) vaccinology","volume":"15(7)doi:10.3390\/v15071440","author":"Williamson","year":"2023","journal-title":"Viruses"},{"issue":"17","key":"10.1016\/j.vaccine.2024.126644_bb0035","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMoa1010971","article-title":"HPV vaccine against anal HPV infection and anal intraepithelial neoplasia","volume":"365","author":"Palefsky","year":"2011","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.vaccine.2024.126644_bb0040","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1093\/cid\/ciab434","article-title":"High Prevalence of Anal High-Grade Squamous Intraepithelial Lesions, and Prevention Through Human Papillomavirus Vaccination, in Young Men Who Have Sex With Men Living With Human Immunodeficiency Virus","volume":"73","author":"Palefsky","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2024.126644_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/v13020144","article-title":"Effectiveness of the Quadrivalent HPV vaccine in preventing anal >\/= HSILs in a Spanish population of HIV+ MSM aged > 26 years","volume":"13","author":"Hidalgo-Tenorio","year":"2021","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.vaccine.2024.126644_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212927","article-title":"Effect of the bivalent HPV vaccine on viral load of vaccine and non-vaccine HPV types in incident clearing and persistent infections in young Dutch females","volume":"14","author":"van der Weele","year":"2019","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.vaccine.2024.126644_bb0055","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/infdis\/jiad080","article-title":"Effects of 2 and 3 vaccinations with the bivalent human papillomavirus (HPV) vaccine on the prevalence and load of HPV in clearing and persistent infections in young women","volume":"228","author":"van Eer","year":"2023","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2024.126644_bb0060","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-035113","article-title":"Lubricant investigation in men to inhibit transmission of HPV infection (LIMIT-HPV): design and methods for a randomised controlled trial","volume":"10","author":"Laurie","year":"2020","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.vaccine.2024.126644_bb0065","first-page":"239","article-title":"Efficacy of a carrageenan gel in preventing anal human papillomavirus (HPV) infection: interim analysis of the lubricant investigation in men to inhibit transmission of HPV infection (LIMIT-HPV) randomised controlled trial","volume":"98","author":"Laurie","year":"2022","journal-title":"Sex Transm Infect"},{"issue":"6","key":"10.1016\/j.vaccine.2024.126644_bb0070","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1128\/JCM.00104-06","article-title":"Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the linear array HPV genotyping test","volume":"44","author":"Coutlee","year":"2006","journal-title":"J Clin Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2024.126644_bb0075","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1002\/jmv.27605","article-title":"Human papillomavirus genotype concordance between Anyplex II HPV28 and linear array HPV genotyping test in anogenital samples","volume":"94","author":"Coutlee","year":"2022","journal-title":"J Med Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2024.126644_bb0080","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ygyno.2019.09.010","article-title":"Viral load of human papillomavirus types 16\/18\/31\/33\/45 as a predictor of cervical intraepithelial neoplasia and cancer by age","volume":"155","author":"Malagon","year":"2019","journal-title":"Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.vaccine.2024.126644_bb0085","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1093\/infdis\/jiz238","article-title":"Human papillomavirus viral load and transmission in young, recently formed heterosexual couples","volume":"220","author":"Wissing","year":"2019","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126644_bb0090","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1158\/1055-9965.EPI-09-0546","article-title":"Marginal and mixed-effects models in the analysis of human papillomavirus natural history data","volume":"19","author":"Xue","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.vaccine.2024.126644_bb0095","doi-asserted-by":"crossref","unstructured":"Efron B, Tibshirani R. Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy. Stat Sci 1986;1(1):54\u201375, 22.","DOI":"10.1214\/ss\/1177013815"},{"issue":"7","key":"10.1016\/j.vaccine.2024.126644_bb0100","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.3390\/v7072802","article-title":"Epithelial tropisms, and the development of neoplasia","volume":"7","author":"Egawa","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2024.126644_bb0105","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-9378-4-8","article-title":"Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline","volume":"4","author":"Schiffman","year":"2009","journal-title":"Infect Agent Cancer"},{"issue":"26","key":"10.1016\/j.vaccine.2024.126644_bb0110","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1016\/j.vaccine.2022.05.019","article-title":"Increases in human papillomavirus vaccine coverage over 12 months among a community-recruited cohort of gay, bisexual, and other men who have sex with men in Canada","volume":"40","author":"Chambers","year":"2022","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2024.126644_bb0115","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1002\/ijc.28509","article-title":"Viral load and short-term natural history of type-specific oncogenic human papillomavirus infections in a high-risk cohort of midadult women","volume":"134","author":"Winer","year":"2014","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.vaccine.2024.126644_bb0120","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/OLQ.0000000000001560","article-title":"Anal Human Papillomavirus Prevalence Among Vaccinated and Unvaccinated Gay, Bisexual, and Other Men Who Have Sex With Men in Canada","volume":"49","author":"Chambers","year":"2022","journal-title":"Sex Transm Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2024.126644_bb0125","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1093\/infdis\/jiaa306","article-title":"Vaccine effectiveness against prevalent anal and Oral human papillomavirus infection among men who have sex with men-United States, 2016-2018","volume":"222","author":"Meites","year":"2020","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2024.126644_bb0130","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/S1473-3099(20)30687-3","article-title":"Prevalence of human papillomavirus in young men who have sex with men after the implementation of gender-neutral HPV vaccination: a repeated cross-sectional study","volume":"21","author":"Chow","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126644_bb0135","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiae412","article-title":"Human papillomavirus prevalence among Australian men aged 18-35 years in 2015-2018 according to vaccination status and sexual preference","author":"Balgovind","year":"2024","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126644_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.909223","article-title":"Prophylactic and therapeutic HPV vaccines: current scenario and perspectives","volume":"12","author":"Mo","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2024.126644_bb0145","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiad005","article-title":"Vaccine effectiveness against 12-month incident and persistent anal human papillomavirus infection among gay, bisexual, and other men who have sex with men","author":"Chambers","year":"2023","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2024.126644_bb0150","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/cid\/ciy274","article-title":"A Randomized, Placebo-Controlled Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Adults Aged 27 Years or Older: AIDS Clinical Trials Group Protocol A5298","volume":"67","author":"Wilkin","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"16","key":"10.1016\/j.vaccine.2024.126644_bb0155","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/j.vaccine.2020.11.076","article-title":"Systematic literature review of cross-protective effect of HPV vaccines based on data from randomized clinical trials and real-world evidence","volume":"39","author":"Brown","year":"2021","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2024.126644_bb0160","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/infdis\/jiy067","article-title":"High Effectiveness of the Bivalent Human Papillomavirus (HPV) Vaccine Against Incident and Persistent HPV Infections up to 6 Years After Vaccination in Young Dutch Women","volume":"217","author":"Donken","year":"2018","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2024.126644_bb0165","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/infdis\/jiy432","article-title":"Substantial decline in prevalence of vaccine-type and nonvaccine-type human papillomavirus (HPV) in vaccinated and unvaccinated girls 5 years after implementing HPV vaccine in Norway","volume":"218","author":"Feiring","year":"2018","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2024.126644_bb0170","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S1473-3099(17)30468-1","article-title":"Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study","volume":"17","author":"Kavanagh","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2024.126644_bb0175","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1038\/bjc.2014.198","article-title":"Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16\/18 and closely related HPV types","volume":"110","author":"Kavanagh","year":"2014","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.vaccine.2024.126644_bb0180","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/infdis\/jiy249","article-title":"The impact of the national HPV vaccination program in England using the bivalent HPV vaccine: surveillance of type-specific HPV in young females, 2010-2016","volume":"218","author":"Mesher","year":"2018","journal-title":"J Infect Dis"},{"issue":"23","key":"10.1016\/j.vaccine.2024.126644_bb0185","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1016\/j.vaccine.2015.04.016","article-title":"Effectiveness of human papillomavirus vaccine against incident and persistent infections among young girls: results from a longitudinal Dutch cohort study","volume":"33","author":"Mollers","year":"2015","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2024.126644_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201653","article-title":"Direct, indirect and total effectiveness of bivalent HPV vaccine in women in Galicia, Spain","volume":"13","author":"Purrinos-Hermida","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.vaccine.2024.126644_bb0195","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ygyno.2019.02.016","article-title":"HPV infections and cytologic abnormalities in vaccinated women 21-34\u00a0years of age: results from the baseline phase of the Onclarity trial","volume":"153","author":"Wright","year":"2019","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126644_bb0200","article-title":"The global demand and supply balance of the human papillomavirus vaccine: implications for the global strategy for the elimination of cervical Cancer","volume":"12","author":"Malvolti","year":"2023","journal-title":"Vaccines (Basel)"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24013264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24013264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T15:13:25Z","timestamp":1739200405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24013264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":39,"alternative-id":["S0264410X24013264"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126644","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HPV vaccination and anal HPV infection in gay, bisexual, and other men who have sex with men","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126644","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126644"}}